Suchergebnisse - "Casamayor, Montserrat"

PubPharm (11)

1

Time to deterioration of patient-reported outcomes in non-small cell lung cancer : exploring different definitions

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2022

von Walding, A. | Skaltsa, K. | Casamayor, M. | +1

ErratumIn: Qual Life Res. 2022 Mar 24;:. - PMID 35325345

2

Correction to : Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2022

von Walding, A. | Skaltsa, K. | Casamayor, M. | +1

ErratumFor: Qual Life Res. 2022 Aug;31(8):2535-2543. - PMID 35099678

3

Correction to: Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions

enthalten in: Quality of life research | 2022

von Walding, A. | Skaltsa, K. | Casamayor, M. | +1

4

Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions

enthalten in: Quality of life research | 2022

von Walding, A. | Skaltsa, K. | Casamayor, M. | +1

5

Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions

enthalten in: Quality of life research | 2022

von Walding, A. | Skaltsa, K. | Casamayor, M. | +1

6

Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions

enthalten in: Quality of life research | 2022

von Walding, A. | Skaltsa, K. | Casamayor, M. | +1

7

Targeted literature review of the global burden of gastric cancer

enthalten in: Ecancermedicalscience | 2018

von Casamayor, M. | Morlock, R. | Maeda, H. | +1

8

Administration of intravenous morphine for acute pain in the emergency department inflicts an economic burden in Europe

enthalten in: Drugs in context | 2018

von Casamayor, M. | DiDonato, K. | Hennebert, M. | +2

9

"De-escalation" strategy using micafungin for the treatment of systemic Candida infections : budget impact in France and Germany

enthalten in: ClinicoEconomics and outcomes research : CEOR | 2017

von van Engen, A. | Casamayor, M. | Kim, S. | +2

10

Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland

enthalten in: Journal of health economics and outcomes research | 2015

von van Engen, A. | Casamayor, M. | Loftus, F. | +4